The MarketReader Minute
π BIIB Rises with CFO Transition and Study Success, MRNA Climbs on New Phase 3 Lung Cancer Trial | Biotech Sector Insights
(IBB) has increased by 1.1% since Friday, buoyed by significant movements among its holdings. Moderna Inc. (MRNA) has experienced a notable rise following the initiation of its Phase 3 clinical trial for lung cancer patients.